InspireMD to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 14
TEL AVIV, Israel, May 07, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, May 14, 2019, to discuss financial results for the first quarter ended March 31, 2019, and provide a corporate update.
Conference Call & Webcast: Tuesday, May 14th @ 8am Eastern Time Within the US: 877-451-6152 Outside the US: 201-389-0879 Conference ID: 13689927 Webcast: http://public.viavid.com/index.php?id=134146
About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.
InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS.
Investor Contacts:Craig ShoreChief Financial OfficerInspireMD, Inc.888-776-6804 email@example.com
Jeremy FefferLifeSci Advisors, LLC212-915-2568 firstname.lastname@example.org